CohBar, Inc.
CohBar, Inc.
Share · US19249J3077 · CWBR (XNAS)
Overview Financial Indicators
No Price
n/a

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
- - 0,00 % 0,00 % -15,55 % -47,44 % -99,50 %

Company Profile for CohBar, Inc. Share

CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes, acute respiratory distress syndrome, cancer, and cardiovascular diseases, such as Alzheimer's disease. Its lead clinical candidate is CB4211, a novel refined analog of the MOTS-c mitochondrial derived peptide, which is in Phase Ib stage of a Phase Ia/Ib clinical trial for the treatment of NASH and obesity. The company's preclinical programs include CB5138 analogs for fibrotic diseases; and CB5064 analogs for COVID-19 associated ARDS. CohBar, Inc. was incorporated in 2007 and is headquartered in Menlo Park, California.

Company Data

Name CohBar, Inc.
Company CohBar, Inc.
Symbol CWBR
Website https://www.cohbar.com
Primary Exchange XNAS NASDAQ
ISIN US19249J3077
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Dr. Pinchas Cohen Dean, M.D., Ph.D.
Country United States of America
Currency USD
Employees 0,0 T
Address 1455 Adams Drive, 94025 Menlo Park
IPO Date 2017-12-15

Ticker Symbols

Name Symbol
NASDAQ CWBR

More Shares

Investors who CohBar, Inc. hold also have the following shares in their portfolio:
DT.BANK 96/26ZO
DT.BANK 96/26ZO Bond
MIDAMERICAN EN. 2048
MIDAMERICAN EN. 2048 Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025